153 related articles for article (PubMed ID: 27626703)
21. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
22. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
[TBL] [Abstract][Full Text] [Related]
23. Activation of
Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
[TBL] [Abstract][Full Text] [Related]
24. PU.1 controls the expression of long noncoding RNA HOTAIRM1 during granulocytic differentiation.
Wei S; Zhao M; Wang X; Li Y; Wang K
J Hematol Oncol; 2016 May; 9(1):44. PubMed ID: 27146823
[TBL] [Abstract][Full Text] [Related]
25. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
Lang L; Li HM; Liu H; Wang YM; Zhang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
[TBL] [Abstract][Full Text] [Related]
26. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway.
Chen ZH; Wang WT; Huang W; Fang K; Sun YM; Liu SR; Luo XQ; Chen YQ
Cell Death Differ; 2017 Feb; 24(2):212-224. PubMed ID: 27740626
[TBL] [Abstract][Full Text] [Related]
27. Expression of PML-RARα is up-regulated during ATRA and arsenics combined induction without influence on long-term prognosis of acute promyelocytic leukemia.
Zhu HH; Qin YZ; Lai YY; Shi HX; Liu YR; Jiang B; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):872-8. PubMed ID: 23998577
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia.
Dekking EH; van der Velden VH; Varro R; Wai H; Böttcher S; Kneba M; Sonneveld E; Koning A; Boeckx N; Van Poecke N; Lucio P; Mendonça A; Sedek L; Szczepański T; Kalina T; Kanderová V; Hoogeveen P; Flores-Montero J; Chillón MC; Orfao A; Almeida J; Evans P; Cullen M; Noordijk AL; Vermeulen PM; de Man MT; Dixon EP; Comans-Bitter WM; van Dongen JJ;
Leukemia; 2012 Sep; 26(9):1976-85. PubMed ID: 22948489
[TBL] [Abstract][Full Text] [Related]
29. A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells.
Song G; Shi L; Guo Y; Yu L; Wang L; Zhang X; Li L; Han Y; Ren X; Guo Q; Bi K; Jiang G
Oncotarget; 2016 Jan; 7(3):3144-57. PubMed ID: 26673819
[TBL] [Abstract][Full Text] [Related]
30. MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia.
Zeng CW; Chen ZH; Zhang XJ; Han BW; Lin KY; Li XJ; Wei PP; Zhang H; Li Y; Chen YQ
Autophagy; 2014 Oct; 10(10):1726-37. PubMed ID: 25126724
[TBL] [Abstract][Full Text] [Related]
31. Autophagic degradation of an oncoprotein.
Bøe SO; Simonsen A
Autophagy; 2010 Oct; 6(7):964-5. PubMed ID: 20724820
[TBL] [Abstract][Full Text] [Related]
32. Tumor suppressor function of Gata2 in acute promyelocytic leukemia.
Katerndahl CDS; Rogers ORS; Day RB; Cai MA; Rooney TP; Helton NM; Hoock M; Ramakrishnan SM; Nonavinkere Srivatsan S; Wartman LD; Miller CA; Ley TJ
Blood; 2021 Sep; 138(13):1148-1161. PubMed ID: 34125173
[TBL] [Abstract][Full Text] [Related]
33. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia.
Chen Z; Tong Y; Li Y; Gao Q; Wang Q; Fu C; Xia Z
PLoS One; 2015; 10(3):e0122530. PubMed ID: 25815789
[TBL] [Abstract][Full Text] [Related]
35. Curing APL through PML/RARA degradation by As2O3.
Lallemand-Breitenbach V; Zhu J; Chen Z; de Thé H
Trends Mol Med; 2012 Jan; 18(1):36-42. PubMed ID: 22056243
[TBL] [Abstract][Full Text] [Related]
36. Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia.
Villiers W; Kelly A; He X; Kaufman-Cook J; Elbasir A; Bensmail H; Lavender P; Dillon R; Mifsud B; Osborne CS
Nat Commun; 2023 Feb; 14(1):724. PubMed ID: 36759620
[TBL] [Abstract][Full Text] [Related]
37. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
38. PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.
Yoshida H; Ichikawa H; Tagata Y; Katsumoto T; Ohnishi K; Akao Y; Naoe T; Pandolfi PP; Kitabayashi I
Mol Cell Biol; 2007 Aug; 27(16):5819-34. PubMed ID: 17562868
[TBL] [Abstract][Full Text] [Related]
39. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation.
Gaillard C; Tokuyasu TA; Rosen G; Sotzen J; Vitaliano-Prunier A; Roy R; Passegué E; de Thé H; Figueroa ME; Kogan SC
Haematologica; 2015 Aug; 100(8):1064-75. PubMed ID: 26088929
[TBL] [Abstract][Full Text] [Related]
40. Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.
Brugnoli F; Lambertini E; Varin-Blank N; Piva R; Marchisio M; Grassilli S; Miscia S; Capitani S; Bertagnolo V
Exp Cell Res; 2010 Jan; 316(1):38-47. PubMed ID: 19747912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
